An injectable signal-amplifying device elicits a specific immune response against malignant glioblastoma-Reference-Cited by-同舟云学术

An injectable signal-amplifying device elicits a specific immune response against malignant glioblastoma

Published:2023-12 Issue:12 Volume:13 Page:5091-5106
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Qiu Qiujun,Chen Sunhui,He Huining,Chen Jixiang,Ding Xinyi,Wang Dongdong,Yang Jiangang,Guo Pengcheng,Li Yang,Kim Jisu,Sheng Jianyong,Gao Chao,Yin Bo,Zheng Shihao,Wang Jianxin

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference73 articles.

1. The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis;de Robles;Neuro Oncol,2015

2. Scale to predict survival after surgery for recurrent glioblastoma multiforme;Park;J Clin Oncol,2010

3. The brain tissue response to surgical injury and its possible contribution to glioma recurrence;Hamard;J Neuro Oncol,2016

4. Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence;Xue;Nat Nanotechnol,2017

5. Pembrolizumab for the treatment of non-small-cell lung cancer;Garon;N Engl J Med,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Size-switchable and dual-targeting nanomedicine for cancer chemoimmunotherapy by potentiating deep tumor penetration and antitumor immunity;Chemical Engineering Journal;2024-08

2. Glioblastoma Therapy: Past, Present and Future;International Journal of Molecular Sciences;2024-02-21

3. Nanobiotechnology-based treatment strategies for malignant relapsed glioma;Journal of Controlled Release;2023-06